No Picture
News

DelMar Pharmaceuticals Announces Fiscal First Quarter 2020 Financial Results and Recent Corporate Updates

SAN DIEGO, Nov. 14, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced its financial results for the quarter ended S… […]

No Picture
News

Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates

– Heron Raises Full-Year 2019 CINV Franchise Net Product Sales Guidance from $115-120 Million to $135 Million –

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on impr… […]

No Picture
News

Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Company on Track for Amphora NDA Resubmission to the U.S. FDAPhase 2b AMPREVENCE Trial Results Anticipated in Q4 2019Management to Host Conference Call Thursday, November 7, 2019 at 11:00 a.m. EST

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ — Evofem Biosci… […]

No Picture
News

Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Conference call scheduled for 8:30 a.m. ET today- IND Application Filed for Phase 2b Study of VK2809 in Biopsy-Confirmed NASH- Clinical Development of VK0214 for X-ALD Expected to Begin 1H20- Balance Sheet Remains Strong with Approximately $290 Million… […]